Robert D. Schreiber
Impact in
- Immunology top 0.01%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- interferon and immune responses
- Immune Response and Inflammation
- Oncology top 0.01%
- Cancer Immunotherapy and Biomarkers
- Cytokine Signaling Pathways and Interactions
- CAR-T cell therapy research
Papers in
- Immunology 246
- Immune Cell Function and Interaction 89
- Immunotherapy and Immune Responses 81
- Immune Response and Inflammation 63
- T-cell and B-cell Immunology 50
- interferon and immune responses 46
- Oncology 121
- Cytokine Signaling Pathways and Interactions 62
- Cancer Immunotherapy and Biomarkers 35
- Co-authors
- Lloyd J. Old (19 shared papers)Gavin P. Dunn (16 shared papers)Mark John Smyth (13 shared papers)Ton N. Schumacher (2 shared papers)Hiroaki Ikeda (10 shared papers)Allen T. Bruce (8 shared papers)Hans J. Müller‐Eberhard (27 shared papers)Kathleen C. F. Sheehan (41 shared papers)
- Journals
- The Journal of Immunology (56 papers)The Journal of Experimental Medicine (27 papers)Proceedings of the National Academy of Sciences (23 papers)Nature (13 papers)Journal of Biological Chemistry (12 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Robert D. Schreiber
387 papers receiving 88.7k citations
Robert D. Schreiber's Hit Papers
Peers
Comparison fields: 5 of 186
- Immunology 52.1k
- Oncology 36.1k
- Cancer Research 7.6k
- Molecular Biology 22.4k
- Hematology 3.2k
Countries citing papers authored by Robert D. Schreiber
This map shows the geographic impact of Robert D. Schreiber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert D. Schreiber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert D. Schreiber more than expected).
Fields of papers citing papers by Robert D. Schreiber
This network shows the impact of papers produced by Robert D. Schreiber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert D. Schreiber. The network helps show where Robert D. Schreiber may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert D. Schreiber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 395 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion Hit paper breakdown → | 2011 | 5124 |
| 2 | Cancer immunoediting: from immunosurveillance to tumor escape Hit paper breakdown → | 2002 | 4166 |
| 3 | Neoantigens in cancer immunotherapy Hit paper breakdown → | 2015 | 3899 |
| 4 | HOW CELLS RESPOND TO INTERFERONS Hit paper breakdown → | 1998 | 3420 |
| 5 | Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death Hit paper breakdown → | 1990 | 3413 |
| 6 | Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression Hit paper breakdown → | 2015 | 2609 |
| 7 | The Three Es of Cancer Immunoediting Hit paper breakdown → | 2004 | 2349 |
| 8 | The Immunobiology of Cancer Immunosurveillance and Immunoediting Hit paper breakdown → | 2004 | 2348 |
| 9 | IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity Hit paper breakdown → | 2001 | 2251 |
| 10 | Batf3 Deficiency Reveals a Critical Role for CD8α + Dendritic Cells in Cytotoxic T Cell Immunity Hit paper breakdown → | 2008 | 1706 |
| 11 | Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens Hit paper breakdown → | 2014 | 1703 |
| 12 | Natural Innate and Adaptive Immunity to Cancer Hit paper breakdown → | 2011 | 1696 |
| 13 | Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway Hit paper breakdown → | 1996 | 1457 |
| 14 | Interferons, immunity and cancer immunoediting Hit paper breakdown → | 2006 | 1320 |
| 15 | Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice Hit paper breakdown → | 1998 | 1209 |
| 16 | The Molecular Cell Biology of Interferon-gamma and its Receptor Hit paper breakdown → | 1993 | 1193 |
| 17 | New insights into cancer immunoediting and its three component phases — elimination, equilibrium and escape Hit paper breakdown → | 2014 | 1189 |
| 18 | Adaptive immunity maintains occult cancer in an equilibrium state Hit paper breakdown → | 2007 | 1118 |
| 19 | Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting Hit paper breakdown → | 2012 | 1047 |
| 20 | Interferon-γ: the Major Mediator of Resistance Against Toxoplasma gondii Hit paper breakdown → | 1988 | 1010 |
About Robert D. Schreiber
Robert D. Schreiber is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Hematology and Cellular and Molecular Neuroscience, having authored 395 papers that have together received 91.9k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (89 papers), Immunotherapy and Immune Responses (81 papers), Immune Response and Inflammation (63 papers), Cytokine Signaling Pathways and Interactions (62 papers), T-cell and B-cell Immunology (50 papers), Monoclonal and Polyclonal Antibodies Research (48 papers), interferon and immune responses (46 papers) and Cancer Immunotherapy and Biomarkers (35 papers). The work is most often cited by research in Immunology (52.1k citations), Oncology (36.1k citations), Cancer Research (7.6k citations), Molecular Biology (22.4k citations) and Hematology (3.2k citations). Robert D. Schreiber has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Lloyd J. Old, Gavin P. Dunn, Mark John Smyth, Ton N. Schumacher, Hiroaki Ikeda, Allen T. Bruce, Hans J. Müller‐Eberhard, Kathleen C. F. Sheehan, George Robert Stark and James Michael White. Their work appears in journals such as The Journal of Immunology, The Journal of Experimental Medicine, Proceedings of the National Academy of Sciences, Nature and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.